Danaher Outperforms Selectis Health in Key Metrics

Danaher's stronger financials, dividends, and analyst ratings make it the superior stock compared to Selectis Health

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Danaher (NYSE:DHR) and Selectis Health (OTCMKTS:GBCS) are both medical companies, but an analysis shows that Danaher is the superior stock. Danaher has higher revenue and earnings, a better dividend, and stronger institutional ownership compared to Selectis Health. Analysts also view Danaher more favorably, with a higher consensus price target indicating potential upside.

Why it matters

This comparison is relevant for investors looking to allocate capital in the medical sector. Danaher's outperformance across key financial and operational metrics suggests it may be the better long-term investment compared to Selectis Health.

The details

Danaher has higher net margins, return on equity, and return on assets than Selectis Health. Danaher pays a higher annual dividend of $1.28 per share with a 0.6% yield, compared to Selectis Health's $0.04 per share and 1.2% yield. Danaher also has a lower payout ratio of 25.4% versus Selectis Health's -14.8%. Danaher's revenue and earnings are also significantly higher than Selectis Health's. Additionally, Danaher is trading at a higher price-to-earnings ratio, indicating it is currently more expensive but also potentially more valuable.

  • Danaher has increased its dividend for 2 consecutive years.

The players

Danaher Corporation

An American conglomerate that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

Selectis Health

A company that owns and operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a range of living services, therapies, and other rehabilitation and healthcare services.

Got photos? Submit your photos here. ›

The takeaway

Danaher's stronger financial performance, dividend, and analyst ratings make it the more attractive investment option compared to Selectis Health in the medical sector.